PET/CT, MRI foretell developing neurofibromas

CHICAGO - Researchers from Spain are following the adage "forewarned is forearmed"...

Read more on AuntMinnieEurope.com

Related Reading:

FDG-PET/CT contributes to anal cancer follow-up

FDG-PET/CT scoring system aids in cervical cancer prognosis

FDG-PET/CT can direct biopsies for pediatric cancer

PET/CT well-suited to follow up organ transplants

PET/CT remains best option for head, neck cancer

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2zvJxdq
via IFTTT

Quantib secures 4.5 million euros of funding

Medical image quantification software company Quantib announced at RSNA 2017...

Read more on AuntMinnieEurope.com

Related Reading:

Quantib secures clearance for brain MR software

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2AjQkbD
via IFTTT

Effect of Xylan Sulfates on Coagulation of Human Blood Plasma

Sulfated derivatives of xylan (isolated from Bétula pubéscens wood) with average molecular weight ~34 kDa, sulfur content of 11.3-17.5%, a degree of substitution of 0.74-1.64 are anticoagulants of direct type of action. Antithrombin and antifactor Xa activities in three tested xylan samples did not differ and reached 30.8-31.8 and 13.5-14.3 U/mg, respectively.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2ADmlyc
via IFTTT

Effect of Moringa oleifera Leaf Capsules on Glycemic Control in Therapy-Naïve Type 2 Diabetes Patients: A Randomized Placebo Controlled Study

Background. Studies showed effects of Moringa oleifera (MO) on lowering blood sugar levels in animal and diabetes patients. The aims of this study were to determine the effect of MO leaf capsules on glucose control in therapy-naïve type 2 diabetes mellitus (T2DM) and to evaluate its safety. Method. This was a prospective randomized placebo controlled study. Therapy-naïve T2DM was randomly assigned to receive either 8 grams per day of MO leaf capsules (MO leaf group) or placebo for 4 weeks. Clinical and laboratory characteristics were recorded at screening and at the end of 4-week study. 9-point plasma glucose was obtained before and every week during the study. Results. Thirty-two T2DM patients were enrolled. The mean age was 55 years and the mean HbA1C was 7.0%. There was no significant difference in FPG and HbA1C between groups. MO leaf group had SBP reduction by 5 mmHg as compared to baseline but this difference had no statistical significance. There were no adverse effects of MO leaf. Conclusions. Moringa oleifera leaf had no effect on glycemic control and no adverse effects in T2DM. Interestingly, this study demonstrated that MO leaf had a tendency on blood pressure reduction in T2DM, and this result needs further investigation.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2AEMSLt
via IFTTT

Low-Grade Mucoepidermoid Carcinoma of the Lacrimal Gland in a Teenaged Patient

Mucoepidermoid carcinoma is the most common malignant, locally invasive tumour of the salivary glands and accounts for approximately 35% of all malignancies of the major and minor salivary glands. Mucoepidermoid carcinoma that originated from the lacrimal gland is exceedingly rare in teenage patients, with only a few cases reported. Herein, we report clinical and radiological findings of a mucoepidermoid carcinoma arising from the lacrimal gland in a 15-year-old boy. We suggest that since preoperative imaging findings are not diagnostic for mucoepidermoid carcinoma, histopathologic examination should be performed for definitive diagnosis. Complete surgical resection is the treatment of choice for low-grade lacrimal gland mucoepidermoid carcinoma.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2Acgmza
via IFTTT

Performance Comparison of Reputation Assessment Techniques Based on Self-Organizing Maps in Wireless Sensor Networks

Many solutions based on machine learning techniques have been proposed in literature aimed at detecting and promptly counteracting various kinds of malicious attack (data violation, clone, sybil, neglect, greed, and DoS attacks), which frequently affect Wireless Sensor Networks (WSNs). Besides recognizing the corrupted or violated information, also the attackers should be identified, in order to activate the proper countermeasures for preserving network’s resources and to mitigate their malicious effects. To this end, techniques adopting Self-Organizing Maps (SOM) for intrusion detection in WSN were revealed to represent a valuable and effective solution to the problem. In this paper, the mechanism, namely, Good Network (GoNe), which is based on SOM and is able to assess the reliability of the sensor nodes, is compared with another relevant and similar work existing in literature. Extensive performance simulations, in terms of nodes’ classification, attacks’ identification, data accuracy, energy consumption, and signalling overhead, have been carried out in order to demonstrate the better feasibility and efficiency of the proposed solution in WSN field.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2AF1ZVn
via IFTTT

Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice

Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used antihyperglycemic agents for the treatment of type 2 diabetes mellitus. Recently, the pleiotropic actions of DPP-4 inhibitors have drawn much attention. In the present study, we aimed to examine whether gemigliptin, a recently developed DPP-4 inhibitor, could protect against cisplatin-induced nephrotoxicity. We showed that pretreatment with gemigliptin attenuated cisplatin-induced renal dysfunction, as shown by analysis of plasma creatinine levels and blood urea nitrogen and histological damage. Elevated plasma levels of active glucagon-like peptide-1 were observed in gemigliptin-pretreated mice after cisplatin treatment, compared to that in cisplatin alone-treated mice. Gemigliptin attenuated cisplatin-induced apoptotic cell death, as assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling and Western blot analysis in the kidneys. Gemigliptin also decreased the plasma levels of tumor necrosis factor-α and monocyte chemoattractant protein-1 and attenuated nuclear staining of nuclear factor kappa-B p65 in the kidneys. In addition, gemigliptin increased the protein expression of heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) in the kidneys of cisplatin-treated mice. Taken together, these results suggest that pretreatment with gemigliptin protects against cisplatin-induced nephrotoxicity in mice, possibly via inhibition of apoptotic cell death and inflammatory responses through induction of HO-1 and NQO1 expression.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2Aev1Kx
via IFTTT